“what i wanted to do was build myself from the percept trial of prehabilitation during autologous stem_cell transplantation in myeloma

HIGHLIGHTS

SUMMARY

Response to allocation in unblinded trials can additionally induce research participation effects or biases post-randomisation, most notably within control participants who may be dissatisfied with allocation. Autologous stem_cell transplantation (ASCT) enables use of high-dose chemotherapy to consolidate therapy and is most frequently used as first line therapy in people living with myeloma deemed ‘fit` enough for intensive anti-cancer therapy. Purposeful sampling was used to select both intervention and control participants, approached in non-sequential order, across the trial period to capture the experiences of participants taking part at different times. Most . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.